View all staff

Emeritus Professor Graham Packham

Connect with Graham

Email: G.K.Packham@soton.ac.uk

Tel: +44 23 8120 6192

Address: Southampton General Hospital, Tremona Road Shirley, SO16 6YD
ORCID
Research Publications
Research Publications

Research

Research groups

Research projects

Active projects

Cancer Research UK Southampton Centre - Non-Clinical Training Award
Sponsor: Cancer Research UK
Early Cancer Research Initiative Network on MBL and MGUS models (ECRIN-M3)
Sponsor: Cancer Research UK

Completed projects

G Packham. LLR. 11053. Oxidative stress in chronic lymphocytic leukaemia
Sponsor: Blood Cancer UK
Using Chemical Probes to investigate redox regulation of Angiogenesis
Sponsor: Gerald Kerkut Charitable Trust
Precision Cancer Medicine: Forefront Technologies at the Clinical Interface Meeting at the University of Southampton, 14th September 2017
Sponsor: Cancer Research UK
Packham, Bloodwise/KKLF, B‐cell receptor signalling in B –cell malignancies: identifying strategies for optimal therapeutic intervention based on common and distinct responses
Sponsor: Blood Cancer UK
CRUK pilot project grant
Sponsor: Cancer Research UK
Smith C1641/A5745 prim c cell lymphomh
Sponsor: Cancer Research UK
KKL408: Biological significance and therapeutic targeting of the B-cell receptor-induced unfolded protein response in Chronic Lymphocytic Leukaemia
Sponsor: The Kay Kendall Leukaemia Fund
G Packham AICR 13-0267 Lectin Mediated B cell receptor
Sponsor: Worldwide Cancer Research
B-cell receptor signalling in B-cell malignancies: Identifying strategies for optimal therapeutic intervention based on common and distinct responses
Sponsor: Cancer Research UK
Packham LLR 14045 Gordon Pillar PhD Studentship Opposing kinase activation in B-cell malignancies
Sponsor: Blood Cancer UK
Prof G Packham - LRF - 07083: Cutaneous T Cell Lymphoma and Histone Deacetylase Inhibitors
Sponsor: Blood Cancer UK
G Packham C2750/A4883
Sponsor: Cancer Research UK
G Packham C2750/A2740
Sponsor: Cancer Research UK
Packham. LLR. 11023. MYC potential target for therapeutic attack in chronic leukaemia
Sponsor: Blood Cancer UK
G Packham CLL B-cell receptor and CXCR4 cross-talk
Sponsor: Global Research Foundation
Packham - CRUK - C15966/A15968 - Personalised Epigenetic Therapy for Follicular Lymphoma (QMUL)
Sponsor: Cancer Research UK
A Ganesan G Packham C2750/A8016
Sponsor: Cancer Research UK
Aquinox Screening Project NXT-POC-01 MTA2
Sponsor: Aquinox Pharmaceuticals (Canada) Inc
Packham. LLR. 13036. Effects of B-Cell receptor stimulation in chronic lymphocytic leukaemia
Sponsor: Blood Cancer UK
P Glynne-Jones - High-Throughput Optical Blood Imaging for the Detection of Rare Cells using Ultrasonic Particle Alignment
Sponsor: EPSRC
Forconi LLR 14037 The influence of altered genetics on B-cell receptor levels and function in CLL
Sponsor: Blood Cancer UK
Steele LLR 12044 autophagy in chronic lymphocytic leukaemia
Sponsor: Blood Cancer UK
Cragg- Gilead Services Inc - Combination of PI3K inhibitors and anti-CD20 mAbs
Sponsor: Gilead Sciences Inc
Prof Stevenson - Tenovus SA59
Sponsor: Tenovus
S Crabb - CRUK - C9317/A20783 - Therapeutic inhibition of the histone demethylase LSD1 to attenuate androgen receptor signalling in prostate cancer that is resistant to new generation AR antagonists
Sponsor: Cancer Research UK
Packham, Bloodwise/KKLF, B‐cell receptor signalling in B –cell malignancies: identifying strategies for optimal therapeutic intervention based on common and distinct responses
Sponsor: The Kay Kendall Leukaemia Fund
J Strefford. LLR. 11052. Characterization of causative loci
Sponsor: Blood Cancer UK
Cancer Research UK Southampton Centre - Clinical Training Award
Sponsor: Cancer Research UK
Steele LLR 14040 B cell receptor signalling is modified by IL-4 in chronic lymphocytic leukaemia CLL
Sponsor: Blood Cancer UK
Hayden Wessex R05 LSD1 Inhibitors for prostate cancer
Sponsor: Wessex Medical Research
CRUK Clinical Academic Training Programme Award
Sponsor: Cancer Research UK
Cragg Kay Kendall Trust Resistance of CLL to anti-CD20 mAbs
Sponsor: The Kay Kendall Leukaemia Fund
Cancer Research UK Southampton Centre
Sponsor: Cancer Research UK
Dr A. Steele: CLL
Sponsor: Blood Cancer UK
Cragg - KKLF - KKL981 - Overcoming tissue-mediated resistance of CLL to anti-CD20 monoclonal antibody therapy.
Sponsor: The Kay Kendall Leukaemia Fund
Dr Strefford ref 06021
Sponsor: Blood Cancer UK
S Crabb PCUK Therapeutic inhibition of the histone demethylase
Sponsor: Prostate Cancer UK
Susceptibility of Patient derived xenograph (PDX) models of Leukemia/lymphoma to cerdulatinib alone or in combination with venetoclax or rituximab
Sponsor: Portola Pharmaceuticals
Exploiting surface Ig glycans of germinal centre lymphomas for diagnosis, prognosis and therapy
Sponsor: Blood Cancer UK
Cutress 2011NovPR39 BAG1 as a therapeutic target in HER2
Sponsor: Breast Cancer Now
Steele - KKLF - Investigating the impact of interleukin-4 in CLL Biology
Sponsor: The Kay Kendall Leukaemia Fund
Prof C Harrison LRF grant 07011
Sponsor: Blood Cancer UK
P Townsend: Proteomic screening for early detection in breast and colorectal cancer
Sponsor: Wessex Medical Research